Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bletilla Formosana in Prediabetic Subjects
NCT07704944Phase 2Not yet recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Bletilla formosana in prediabetes, sponsored by Chang Gung Memorial Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Bletilla formosana
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT07704944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704944.